Are you curious about how natural or body-based therapies could be used to help manage your Crohn’s or colitis? Do you want to hear about the latest scientific evidence for using complementary therapies in IBD?
Watch this webinar recording to learn about the different types of complementary and body-based interventions that may be integrated with your IBD treatment plan. An expert gastroenterologist will discuss the potential risks and benefits of the natural therapies (e.g. herbal remedies, diet supplements, probiotics, curcumin) and body-based practices (e.g. acupuncture, chiropractic, yoga, exercise) for Crohn’s disease and ulcerative colitis. You will also learn about scientific evidence suggest on these interventions.
Expert Speaker
Dr. Adam Weizman
Mount Sinai Hospital
Dr. Adam Weizman is a distinguished gastroenterologist and the Medical Director of the Centre for Inflammatory Bowel Disease (IBD) at Mount Sinai Hospital in Toronto. He also serves as an Associate Professor of Medicine at the University of Toronto. Dr. Weizman earned his medical degree from the University of Manitoba, followed by residency in Internal Medicine and a Gastroenterology fellowship at the University of Toronto. He further specialized with an advanced IBD fellowship at Cedars-Sinai Medical Center in Los Angeles and completed a Master’s degree in Quality Improvement and Patient Safety at the University of Toronto .
Since joining Mount Sinai Hospital in 2013, Dr. Weizman has been instrumental in advancing IBD care through clinical practice, research, and education. As Head of Quality and Patient Safety for the Division of Gastroenterology at both Mount Sinai Hospital and the University Health Network, he focuses on enhancing healthcare delivery and outcomes for patients with IBD. His research interests include healthcare quality and health outcomes, with a particular emphasis on IBD.
Dr. Weizman is actively involved in teaching at both undergraduate and postgraduate levels, serving as a course tutor for medical students and supervising internal medicine and gastroenterology trainees . He is also a member of the Scientific Committee of the Canadian IBD Research Consortium, contributing to national research initiatives in the field . Under his leadership, Mount Sinai's IBD Centre has grown to become the largest program of its kind in Canada, renowned for its comprehensive, patient-centered approach to care.